A phase II study of sotorasib plus panitumumab rechallenge in patients with KRAS G12C mutant metastatic colorectal cancer

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2026
This article has no abstract
Epistemonikos ID: a7174e7721036e0493a23ac01e88881123bfecf8
First added on: Oct 10, 2026